Home - Journal of Gastrointestinal Oncology

Interviews with Outstanding Authors (2024)

In 2024, many JGO authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspective and insightful view as authors.

Reviewer of the Month (2024)

In 2024, JGO reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

JGO Annual Report (2023)

Greetings from the editorial office of Journal of Gastrointestinal Oncology (JGO).

We are glad to present the 2023 Annual Report of JGO, which has shown the types, pageviews, readers of JGO articles and the ongoing special series in 2023. The newly released 2023 Impact Factor of JGO is 2.1.

We would like to extend our sincere gratitude to our editorial board members, guest editors, reviewers, authors and readers. We wish you a happy, healthy and prosperous 2024 and we look forward to working with you to continue the success of JGO.

New Impact Factor for Journal of Gastrointestinal Oncology: 2.1

We are pleased to announce that the Journal of Gastrointestinal Oncology (JGO) has attained its latest impact factor update for the 2022 citation year: 2.1.

We will strive to follow the best practices in publishing. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their valuable contributions.

Journal of Gastrointestinal Oncology 2022 CiteScore Released: 3.1

We are pleased to announce that the Journal of Gastrointestinal Oncology (JGO) has received its 2022 CiteScore: 3.1, ranking 87 out of 149 journals in the Gastroenterology category.

Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking.

Journal of Gastrointestinal Oncology (JGO) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Journal of Gastrointestinal Oncology (JGO) is among the list of COPE membership.

Implementation of transparent peer review at Journal of Gastrointestinal Oncology (JGO)

Editorial office, Journal of Gastrointestinal Oncology

With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to implement a transparent peer review process as an option for all manuscripts submitted to JGO from June 11, 2020.

Editors’ Choice

Peering into the darkness of drug-induced thrombotic microangiopathy: complement, are you in there?

Conventional management of drug-induced thrombotic microangiopathies (DI-TMAs) is centered around drug cessation and supportive care. This can be quite troublesome since many of these offending medications are important antineoplastic or immunosuppressive drugs that may not have equivalent alternatives.

Editors’ Choice

Evolution of pancreatic surgery over time and effects of centralization—a single-center retrospective cohort study

Kaplan-Meier curves of long-term survival, stratified by time quartiles.

Editors’ Choice

Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis

Circos plots histograms demonstrating mutational burden, structural patterns and substitution base signatures. (A) A patient with MLH1 driven MMRd cholangiocarcinoma noting the burden of small indels. (B) A patient with a prior history of mantle cell lymphoma and evidence of signature 3 usually identifying with homologous recombination deficiency. (C) A patient with UC-PSC, a high TMB, and predominance of SBS17.

Editors’ Choice

An unusual paraesophageal and diaphragmatic SDHA-deficient gastrointestinal stromal tumor (GIST) metastases case report

Radiographic images. (A) Axial image demonstrating mediastinal metastatic lesions (tumor highlighted by red arrow). (B) Coronal image fully showing tumor extension from the diaphragm to subcarinal space (tumor highlighted by red arrow). (C) Satellite diaphragmatic mass (highlighted by red arrow).

‹ ›

Vol 15, No 2 (April, 2024)

About jgo

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: jgo@amepc.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Original Article

Computer-aided diagnostic system with automated deep learning method based on the AutoGluon framework improved the diagnostic accuracy of early esophageal cancer

Xin Gao, Jiaxi Lin, Changju Qu, Chao Wang, Airong Wu, Jinzhou Zhu, Chunfang Xu

PDF Pages: 535-543 Full Text (70) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases

Justin A. Drake, Andrew J. Sinnamon, Samir Saeed, Rutika Mehta, Russell F. Palm, Jobelle J. Baldonado, Jacques P. Fontaine, Jose M. Pimiento

PDF Pages: 544-554 Full Text (62) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Effect of perioperative blood transfusion on complications and prognosis after radical gastrectomy in elderly patients: a retrospective study of 1,666 cases

Jinqiang Liu, Kunli Du, Rui Zhang, Wei Zhou, Gaozan Zheng, Pengfei Wang, Jianyong Zheng, Fan Feng

PDF Pages: 555-565 Full Text (69) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Clinical outcome of non-curative endoscopic submucosal dissection for early gastric cancer

Xiaoqian Ma, Wenjuan Xu, Lingyu Qi, Qian Zhang, Xiujing Sun, Shutian Zhang

PDF Pages: 566-576 Full Text (56) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Contribution of genetic polymorphism in ABCB1 to individual variations of imatinib plasma levels in patients with gastrointestinal stromal tumor

Yinggang Ge, Huili Bai, Alessandro Mazzocca, Jun Zhang, Ziwei Wang, Xingye Wu

PDF Pages: 577-583 Full Text (55) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective study

Yulu Fang, Yifan Zhao, Xiaofu Yu, Shuxun Liu, Gang Tao, Haijun Zhong, Hai Xiang, Yunshan Yang, Zhong Shi

PDF Pages: 585-596 Full Text (86) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

The exploration of surgery and survival prediction in patients with peritoneal metastasis from gastric adenocarcinoma based on the SEER database

Yang Shen, Shuhong Yu, Yuefeng Zhang, Siyu Wang, Jiayu Chen, Yangtao Xu, Xinyao Hu, Jiayi Li, Shan Jiang, Ling Wang, Le Xu, Zhuolin Zhou, Junjian Deng, Biao Chen, Ximing Xu

PDF Pages: 597-611 Full Text (66) Reporting Checklist Peer Review File COI Form Open Access

Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study

Rong-Rong Li, Hui-Jun Zhou, De-Yu Zeng, Shao-Feng Jiang, Wu Liu, Petter Frühling, Zhen-Yang Liu

PDF Pages: 612-629 Full Text (82) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort study

Jialong Tao, Yingtian Zhang, Yanjie Wang, Sijia Huang, Wenwen Gao, Liya Dai, Zhengyang Feng, Chenchen Jiao, Yusong Zhang

PDF Pages: 630-640 Full Text (67) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma

Zhe Sun, Haodi Wang, Yao Xu, Yichi Liu, Lu Wang, Ruijie Zhou, Runlong Zhou, Wenjian Ma, Tongcun Zhang

PDF Pages: 641-667 Full Text (79) Reporting Checklist Peer Review File COI Form Open Access

Construction and validation of a nomogram for predicting disease-free survival after radical resection of rectal cancer using perioperative inflammatory indicators

Jiayi Sun, Xinzhi Zhong, Xiangqi Yin, Huimin Wu, Lei Li, Ruiling Yang

PDF Pages: 668-680 Full Text (52) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Survival in metastatic microsatellite-stable colorectal cancer correlated with tumor mutation burden and mutations identified by next-generation sequencing

Nicholas Taflin, Lyndsey Sandow, Rajat Thawani, Shangyuan Ye, Adel Kardosh, Christopher L. Corless, Emerson Y. Chen

PDF Pages: 681-688 Full Text (78) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis

Linhui Zhu, Xuan Ye, Youjun She, Wensheng Liu, Kiyoshi Hasegawa, Roberta Elisa Rossi, Qiong Du, Qing Zhai

PDF Pages: 689-709 Full Text (71) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Efficacy and safety analysis of selective hepatic vein occlusion combined with arterial chemoembolization versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma

Jiang Chang, Haochen Wang, Jian Li, Long Jin

PDF Pages: 710-720 Full Text (48) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional transarterial chemoembolization on survival outcomes

Phan Nhan Hien, Ho Jong Chun, Jung Suk Oh, Su Ho Kim, Byung Gil Choi

PDF Pages: 721-729 Full Text (87) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity

Meng Wang, Lin Liu, Xinze Li, Wenna Jiang, Jiawei Xiao, Qianhui Hao, Jiayi Wang, Abhinav V. Reddy, Alice Talbot, Shinichi Ikuta, Derun Tian, Li Ren

PDF Pages: 730-746 Full Text (82) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based study

Minghao Zhang, Nana Li, Kuanjie Ma, Lin Wang, Yurong Cai, Zhen Liu

PDF Pages: 747-754 Full Text (70) Reporting Checklist Peer Review File COI Form Open Access

Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank

Emmy Borgmästars, Sara Jacobson, Maja Simm, Mattias Johansson, Ola Billing, Christina Lundin, Hanna Nyström, Daniel Öhlund, Zelmina Lubovac-Pilav, Pär Jonsson, Oskar Franklin, Malin Sund

PDF Pages: 755-767 Full Text (88) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a single-institution case series

Jeremy D. Ward, Mark Fowler, Ariannette Robledo-Gomez, Shaun M. Goodyear, Adel Kardosh, Eizaburo Sasatomi

PDF Pages: 768-779 Full Text (79) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Case Series

Regorafenib for patients with progression of advanced hepatocellular carcinoma after treatment with atezolizumab plus bevacizumab: a case series

Wendi Kang, Hongjiang Fu, Yingen Luo, Danielle M. Noreika, Tianhao Cong, Hang Li, Zhengqiang Yang

PDF Pages: 780-787 Full Text (40) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report

Sonia Gowda, Lyndsey Sandow, Michael C. Heinrich

PDF Pages: 788-793 Full Text (68) Reporting Checklist Peer Review File COI Form Open Access

Transarterial chemoembolization for omental vein tumor thrombosis in hepatocellular carcinoma: a case report

Phan Nhan Hien, Ho Jong Chun, Su Ho Kim

PDF Pages: 794-799 Full Text (61) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

The emerging role of intra-tumoral bacteria

Giovanni Brandi, Giorgio Frega

PDF Pages: 800-802 Full Text (90) Peer Review File COI Form Open Access

Letter to the Editor

A description of the correction of data error and the direction of in-depth research

Jian Xiong, Weiling Yin, Xilin Du, Zhonghua Luo

PDF Pages: 803-804 Full Text (55) COI Form Open Access

Is brachial artery approach safe for hepatic artery infusion chemotherapy?

Yunlong Dai, Chang Yu, Qingbo Feng

PDF Pages: 805-806 Full Text (57) COI Form Open Access

Original Article

The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal

Umashankar K Ballehaninna, Ronald S Chamberlain

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity

Dongyun Yang, Andrew Hendifar, Cosima Lenz, Kayo Togawa, Felicitas Lenz, Georg Lurje, Alexandra Pohl, Thomas Winder, Yan Ning, Susan Groshen, Heinz-Josef Lenz

Review Article

Imaging of pancreatic cancer: An overview

Pavan Tummala, Omer Junaidi, Banke Agarwal

Immunohistochemical features of the gastrointestinal tract tumors

Hannah H. Wong, Peiguo Chu

Techniques of hepatic resection

Robert J. Aragon, Naveenraj L. Solomon

Gastric cancer: Classification, histology and application of molecular pathology

Bing Hu, Nassim El Hajj, Scott Sittler, Nancy Lammert, Robert Barnes, Aurelia Meloni-Ehrig

HDR brachytherapy for anal cancer

Peter Niehoff, Gyoergy Kovács

Colorectal carcinoma: Pathologic aspects

Matthew Fleming, Sreelakshmi Ravula, Sergei F. Tatishchev, Hanlin L. Wang

Review Articles

Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases

Yue Zhu, Nader Hanna, Cherif Boutros, H. Richard Alexander, Jr.

Original Article

The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal

Umashankar K Ballehaninna, Ronald S Chamberlain

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity

Dongyun Yang, Andrew Hendifar, Cosima Lenz, Kayo Togawa, Felicitas Lenz, Georg Lurje, Alexandra Pohl, Thomas Winder, Yan Ning, Susan Groshen, Heinz-Josef Lenz

Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29

Jiezhong Chen, Xu-Feng Huang, Liang Qiao, Andrew Katsifis

Exosome can prevent RNase from degrading microRNA in feces

Yoshikatsu Koga, Masahiro Yasunaga, Yoshihiro Moriya, Takayuki Akasu, Shin Fujita, Seiichiro Yamamoto, Yasuhiro Matsumura

Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for ⁹⁰Y resin microspheres

Andrew S. Kennedy, David Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, Eduardo Ehrenwald, Samir Kanani, Steven C. Rose, Charles W. Nutting, Fred M. Moeslein, Michael A. Savin, Sabine Schirm, Samuel G. Putnam III, Navesh K. Sharma, Eric A. Wang

Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience

Nadia K Malik, Kilian Salerno May, Rameela Chandrasekhar, Wen Wee Ma, Leayn Flaherty, Renuka Iyer, John Gibbs, Boris Kuvshinoff, Gregory Wilding, Graham Warren, Gary Y Yang

Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials

Vinayak Nagaraja, Guy D. Eslick, Michael R. Cox

Self-expanding metal stents (SEMS) provide superior outcomes compared to plastic stents for pancreatic cancer patients undergoing neoadjuvant therapy

Megan A. Adams, Michelle A. Anderson, James D. Myles, Shokoufeh Khalatbari, James M. Scheiman

Review Article

Gastric cancer: Classification, histology and application of molecular pathology

Bing Hu, Nassim El Hajj, Scott Sittler, Nancy Lammert, Robert Barnes, Aurelia Meloni-Ehrig

Colorectal carcinoma: Pathologic aspects

Matthew Fleming, Sreelakshmi Ravula, Sergei F. Tatishchev, Hanlin L. Wang

Diet and supplements and their impact on colorectal cancer

Marinos Pericleous, Dalvinder Mandair, Martyn E. Caplin

HIFU for palliative treatment of pancreatic cancer

Tatiana D. Khokhlova, Joo Ha Hwang

Gastrointestinal stromal tumor

Xiaohui Zhao, Changjun Yue

Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features

Marnelli A. Bautista-Quach, Christopher D. Ake, Mingyi Chen, Jun Wang

Imaging of pancreatic cancer: An overview

Pavan Tummala, Omer Junaidi, Banke Agarwal

Preoperative imaging for hepatic resection of colorectal cancer metastasis

Timothy L. Frankel, Richard Kinh Gian Do, William R. Jarnagin

Techniques of hepatic resection

Robert J. Aragon, Naveenraj L. Solomon

Liver-directed therapies in metastatic colorectal cancer

Margaret E. Clark, Richard R. Smith

Imaging preoperatively for pancreatic adenocarcinoma

Jason Alan Pietryga, Desiree E. Morgan

Immunohistochemical features of the gastrointestinal tract tumors

Hannah H. Wong, Peiguo Chu

Current and future systemic treatment options in metastatic pancreatic cancer

Cagatay Arslan, Suayib Yalcin

Radioembolization of hepatic tumors

Andrew Kennedy

FDG PET imaging in the staging and management of gastric cancer

Shane Hopkins, Gary Y Yang

Stereotactic body radiation therapy for liver metastases

Marta Scorsetti, Elena Clerici, Tiziana Comito

The role of epithelial-mesenchymal transition in pancreatic cancer

Jen-Jung Pan, Muh-Hwa Yang

Surgical management of gastric cancer: the East vs. West perspective

Maki Yamamoto, Omar M. Rashid, Joyce Wong

Human papillomavirus tumor infection in esophageal squamous cell carcinoma

Ethan B. Ludmir, Sarah J. Stephens, Manisha Palta, Christopher G. Willett, Brian G. Czito

Molecular pathology of pancreatic neuroendocrine tumors

Mingyi Chen, Michael Van Ness, Yangtong Guo, Jeffrey Gregg

Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations

Alexander G. Raufi, Samuel J. Klempner

Original Articles

Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis

Vinayak Nagaraja, Guy D. Eslick

Review Articles

Understanding and targeting resistance to anti-angiogenic therapies

Jeffrey M. Clarke, Herbert I. Hurwitz

Markers of resistance to anti-EGFR therapy in colorectal cancer

Walid Shaib, Reena Mahajan, Bassel El-Rayes

Original Article

Bax expression is a candidate prognostic and predictive marker of colorectal cancer

Venkat R Katkoori, Catalina Suarez-Cuervo, Chandrakumar Shanmugam, Nirag C Jhala, Tom Callens, Ludwine Messiaen, James Posey III, Harvey L Bumpers, Sreelatha Meleth, William E Grizzle, Upender Manne

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity

Dongyun Yang, Andrew Hendifar, Cosima Lenz, Kayo Togawa, Felicitas Lenz, Georg Lurje, Alexandra Pohl, Thomas Winder, Yan Ning, Susan Groshen, Heinz-Josef Lenz

The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma

William A. Hall, Lauren E. Colbert, Dana Nickleach, Jeffrey Switchenko, Yuan Liu, Theresa Gillespie, Joseph Lipscomb, Claire Hardy, David A. Kooby, Roshan S. Prabhu, John Kauh, Jerome C. Landry

Overall survival analysis of neoadjuvant chemoradiotherapy and esophagectomy for esophageal cancer

Faisal A. Siddiqui, Katelyn M. Atkins, Brian S. Diggs, Charles R. Thomas Jr, John G. Hunter, James P. Dolan

Radiotherapy patterns of care in gastric adenocarcinoma: a single institution experience

Jessica Cheng, Malcolm H. Squires III, John L. Mikell, Sarah B. Fisher, Charles A. Staley III, David A. Kooby, Bassel F. El-Rayes, Walter J. Curran Jr, William A. Hall, Lauren E. Colbert, Joseph W. Shelton, Shishir K. Maithel, Jerome Landry, David S. Yu

Impact of intensity modulated radiation therapy on survival in anal cancer

Jaymin Jhaveri, Lael Rayfield, Yuan Liu, Mudit Chowdhary, Sibo Tian, Richard J. Cassidy, Theresa Gillespie, Pretesh R. Patel, Jerome C. Landry, Kirtesh R. Patel

Immune profiling of microsatellite instability-high and polymerase ε (POLE)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy

Chongkai Wang, Jun Gong, Travis Y. Tu, Peter P. Lee, Marwan Fakih

Palliative care and end-of-life health care utilization in elderly patients with pancreatic cancer

Nizar Bhulani, Arjun Gupta, Ang Gao, Jenny Li, Chad Guenther, Chul Ahn, Elizabeth Paulk, Stephanie Houck, Muhammad S. Beg

Distinctive features of gastrointestinal stromal tumors arising from the colon and rectum

Rebecca Zhu, Fangfang Liu, Gabriella Grisotti, Javier Pérez-Irizarry, Charles H. Cha, Caroline H. Johnson, Daniel J. Boffa, Dale Han, Kimberly L. Johung, Yawei Zhang, Sajid A. Khan

Review Article

Alcoholic liver disease- Hepatocellular carcinoma transformation

Samuel W French, James Lee, Jim Zhong, Timothy R Morgan, Virgil Buslon, William Lungo, Barbara A French

Pancreatic adenocarcinoma pathology: changing “landscape”

Lodewijk A. A. Brosens, Wenzel M. Hackeng, G. Johan Offerhaus, Ralph H. Hruban, Laura D. Wood

Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classification

Jeremy Chuang, Jun Gong, Samuel J. Klempner, Yanghee Woo, Joseph Chao

Original Articles

Socioeconomic status, p53 abnormalities, and colorectal cancer

Emily Vogtmann, Chandrakumar Shanmugam, Venkat R. Katkoori, John Waterbor, Upender Manne

Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma

Parvin F. Peddi, May Cho, Jian Wang, Feng Gao, Andrea Wang-Gillam

Below are the latest Journal of Gastrointestinal Oncology articles published online ahead of print publication.

Original Article

Predicting bowel function after diverting stoma closure in patients with rectal cancer

Zhang Wang, Shengli Shao, Lu Liu, Qiyi Lu, Lei Mu, Jichao Qin

Published online: 25 April 2024

Editorial

Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers

Matthew D. Bloom, Babar Bashir

Published online: 25 April 2024

Review Article

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular cancer—a narrative review and expert opinion

Sabine Gerum, Brane Grambozov, Falk Roeder

Published online: 02 February 2024

Review Article

MR-linac based radiation therapy in gastrointestinal cancers: a narrative review

Jonas Ristau, Juliane Hörner-Rieber, Stefan A. Körber

Published online: 01 September 2023

Review Article

Stereotactic body radiation therapy in non-liver colorectal metastases: a scoping review

Maria Ausilia Teriaca, Maria Massaro, Ciro Franzese, Tiziana Comito, Marta Scorsetti

Published online: 30 August 2023

Review Article

Stereotactic body radiation therapy for colorectal cancer liver metastases

Jelena Lukovic, Laura A. Dawson

Published online: 29 June 2023

Journal highlight more

Journal of Gastrointestinal Oncology is an open-access, international peer-reviewed journal indexed by PubMed/PubMed Central, Science Citation Index Expanded (SCIE), with a focus on the diagnosis, prevention and clinical investigations of gastrointestinal cancer, including but not limited to, multimodality therapy, markers, imaging and tumor biology.